Insulin infusion in acute illness

Journal of Clinical Investigation

Volumn 115, Issue 8, 2005, Pages 2069-2072

  Dandona, Paresh ^a,b   Mohanty, Priya ^a   Chaudhuri, Ajay ^a   Garg, Rajesh ^a   Aljada, Ahmad ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b Diabetes Endocrinology Center of Western New York   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; NITRIC OXIDE;

ACUTE DISEASE; ANTIINFLAMMATORY ACTIVITY; DRUG MECHANISM; HORMONE ACTION; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INSULIN INFUSION; INSULIN TREATMENT; INTENSIVE CARE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

ACUTE DISEASE; ANIMALS; BLOOD GLUCOSE; HEPATOCYTES; HUMANS; HYPERGLYCEMIA; INFLAMMATION; INSULIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II;

EID: 23644448735     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI26045     Document Type: Review

References (22)

1. Mohanty, P., et al. 2000. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J. Clin. Endocrinol. Metab. 85:2970-2973.
2. Tripathy, D., et al. 2003. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes. 52:2882-2887.
3. Dhindsa, S., et al. 2004. Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factor-kappaB in mononuclear cells. Metabolism. 53:330-334.
4. Dandona, P., et al. 2001. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J. Clin. Endocrinol. Metab. 86:3257-3265.
5. Aljada, A., Ghanim, H., Mohanty, P., Kapur, N., and Dandona, P. 2002. Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. J. Clin. Endocrinol. Metab. 87:1419-1422.
6. Van den Berghe, G., et al. 2001. Intensive insulin therapy in the critically ill patients. N. Engl. J. Med. 345:1359-1367.
7. Hansen, T.K., Thiel, S., Wouters, P.J., Christiansen, J.S., and Van den Berghe, G. 2003. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J. Clin. Endocrinol. Metab. 88:1082-1088.
8. Vanhorebeek, I., et al. 2005. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet. 365:53-59.
9. Chaudhuri, A., et al. 2004. Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation. 109:849-854.
10. Grover, A., et al. 1995. Insulin attenuates norepinephrine-induced venoconstriction. An ultrasonographic study. Hypertension. 25:779-784.
11. Steinberg, H.O., Brechtel, G., Johnson, A., Fineberg, N., and Baron, A.D. 1994. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J. Clin. Invest. 94:1172-1179.
12. Trovati, M., et al. 1994. Insulin increases guanosine-3′,5′- cyclic monophosphate in human platelets. A mechanism involved in the insulin anti-aggregating effect. Diabetes. 43:1015-1019.
13. Aljada, A., and Dandona, P. 2000. Effect of insulin on human aortic endothelial nitric oxide synthase. Metabolism. 49:147-150.
14. Zeng, G., and Quon, M.J. 1996. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells J. Clin. Invest. 98:894-898.
15. Esposito, K., et al. 2002. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 106:2067-2072.
16. Aljada, A., et al. 2004. Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities, in the expression of tissue factor and matrix metalloproteinase in mononuclear cells, and in plasma tissue factor and matrix metalloproteinase concentrations. Am. J. Clin. Nutr. 80:51-57.
17. Furnary, A.P., et al. 2003. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg. 125:1007-1021.
18. Jeschke, M.G., Klein, D., and Herndon, D.N. 2004. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann. Surg. 239:553-560.
19. Krinsley, J.S. 2004. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin. Proc. 79:992-1000.
20. Jeschke, M.G., Klein, D., Bolder, U., and Einspanier, R. 2004. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology. 145:4084-4093.
21. Stentz, F.B., Umpierrez, G.E., Cuervo, R., and Kitabchi, A.E. 2004. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes. 53:2079-2086.
22. Langouche, L., et al. 2005. Intensive insulin therapy protects the endothelium of critically ill patients. J. Clin. Invest. 115:2277-2286. doi:10.1172/JCI25385.